Aortic-brachial stiffness mismatch as potential marker of subclinical arterial damage in patients with rheumatoid arthritis

Capa

Citar

Texto integral

Resumo

Aortic-brachial stiffness mismatch is a potential new marker of a subclinical vascular damage that has never been studied in patients with rheumatic diseases. The aim of the study was to assess the frequency of arterial stiffness mismatch in rheumatoid arthritis (RA) and to evaluate its clinical associations. Materials and Methods. The study group included 85 patients with RA (males 22.4 %, aged 59.7 ± 14.3 years, hypertension in 65 %, mean disease activity score (DAS-28 (C-reactive protein) 3.7 ± 1.1), and the control group included 40 subjects matched by gender, age and risk factors. The study methods included measurements of clinical and ambulatory brachial and aortic blood pressure (BP) (BPLab-Vasotens), arterial stiffness parameters parameters (applanation tonometry, SphygmoCorAtCor), cardio-ankle vascular index (VaSera) and cardio-vascular risk assessments using the SCORE, American College of Cardiology/American Heart Association (ACC/AHA) 2013 pooled cohort equations and QRisk2 scoring systems. The arterial stiffness gradient was calculated as a ratio between carotid-femoral (cf) and carotid-radial (cr) pulse wave velocity, and its elevation of ≥ 1 was considered as arterial stiffness mismatch. A p-value of < 0.05 was considered significant. Results and Discussion. The mean stiffness gradient in RA patients without and with hypertension was 1.1 ± 0.1 and 1.4 ± 0.4, respectively (р < 0.001); in controls, 0.99 ± 0.2 and 1.3 ± 0.3, respectively (р < 0.001). The frequency of stiffness mismatch in the RA group was significantly higher compared to the controls in the whole study population (88.2 % vs 65 % (р = 0.002)) and in both normotensive and hypertensive subgroups (76.7 % vs 43.8 % (p = 0.03), and 94.5 % vs 79.2 % (p = 0.04), respectively). The same trend was observed in the subgroups with normal carotid-femoral pulse wave velocity: arterial stiffness mismatch was present in 82.1 % of RA patients vs. 51.9 % control subjects (p = 0.004). The stiffness gradient was associated with age (r = 0.63), hypertension duration (r = 0.56), cardio-vascular risk by the ACC/AHA 2013 (r = 0.69) and Qrisk2 (r = 0.7) scoring systems, nocturnal aortic systolic BP (r = 0.53), cardio-ankle vascular index (r = 0.60) and diurnal index of brachial systolic BP (r = -0.4). Significant differences in stiffness gradient values were observed in the subgroups based on elevation of aortic systolic BP and pulse wave velocity above individual reference values, aortic pulse pressure > 50 mmHg, cardio-ankle vascular index > 9, presence of high cardio-vascular risk, masked and nocturnal hypertension, and non-dipping. Conclusion. Patients with RA are characterized by higher frequency of arterial stiffness mismatch compared to controls, irrespective of the history of hypertension or the values of carotid-femoral pulse wave velocity. Arterial stiffness mismatch is associated with unfavorable 24-h BP profile, higher frequency of nocturnal hypertension and cardio-vascular risk.

Sobre autores

Elena Troitskaya

RUDN University

Autor responsável pela correspondência
Email: troitskaya-ea@rudn.ru
ORCID ID: 0000-0003-1756-7583
Código SPIN: 6097-9775
Moscow, Russian Federation

Sergei Velmakin

RUDN University

Email: troitskaya-ea@rudn.ru
ORCID ID: 0000-0003-0410-466X
Código SPIN: 6789-3036
Moscow, Russian Federation

Lubov Goreva

RUDN University

Email: troitskaya-ea@rudn.ru
ORCID ID: 0000-0002-5456-8545
Código SPIN: 7613-4089
Moscow, Russian Federation

Zhanna Kobalava

RUDN University

Email: troitskaya-ea@rudn.ru
ORCID ID: 0000-0002-5873-1768
Código SPIN: 9828-5409
Moscow, Russian Federation

Bibliografia

  1. Avina-­Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71:1524-9. doi: 10.1136/annrheumdis-2011-200726.
  2. Bacon PA, Stevens RJ, Carruthers DM, Young SP, Kitas GD. Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev. 2002;1(6):338-47. doi: 10.1016/s1568-9972(02)00100-3.
  3. Puttevils D, De Vusser P, Geusens P, Dens J. Increased cardiovascular risk in patients with rheumatoid arthritis: an overview. Acta Cardiol. 2014;69(2):111-8. doi: 10.1080/ac.69.2.3017291.
  4. Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, Vasan RS, Levy D. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension. 2004;43(6):1239-1245. doi: 10.1161/01.HYP.0000128420.01881.aa.
  5. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR; ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-­Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46(9):1753-1760. doi: 10.1016/j.jacc.2005.07.037.
  6. Bossuyt J, Engelen L, Ferreira I, Stehouwer CD, Boutouyrie P, Laurent S, Segers P, Reesink K, Van Bortel LM; Reference Values for Arterial Measurements Collaboration. Reference values for local arterial stiffness. Part B: femoral artery. J Hypertens. 2015;33(10):1997-2009. doi: 10.1097/HJH.0000000000000655.
  7. Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME. Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Arterioscler Thromb. 1993;13(1):90-97. doi: 10.1161/01.atv.13.1.90.
  8. Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y, Inoguchi T, Maeda Y, Kohara K, Tabara Y, Nakamura M, Ohkubo T, Watada H, Munakata M, Ohishi M, Ito N, Nakamura M, Shoji T, Vlachopoulos C, Yamashina A; Collaborative Group for J-BAVEL (Japan Brachial-­Ankle Pulse Wave Velocity Individual Participant Data Meta-­Analysis of Prospective Studies). Brachial-­ankle pulse wave velocity and the risk prediction of cardiovascular disease: an individual participant data meta-analysis. Hypertension. 2017;69(6):1045-1052. doi: 10.1161/HYPERTENSIONAHA.117.09097.
  9. Yu WC, Chuang SY, Lin YP, Chen CH. Brachial-­ankle vs carotid-­femoral pulse wave velocity as a determinant of cardiovascular structure and function. J Hum Hypertens. 2008;22(1):24-31. doi: 10.1038/sj.jhh.1002259.
  10. Lu Y, Zhu M, Bai B, Chi C, Yu S, Teliewubai J, Xu H, Wang K, Xiong J, Zhou Y, Ji H, Fan X, Yu X, Li J, Blacher J, Zhang Y, Xu Y. Comparison of carotid-­femoral and brachial-­ankle pulse-wave velocity in association with target organ damage in the community-­dwelling elderly Chinese: The Northern Shanghai Study. J Am Heart Assoc. 2017;6(2): e004168. doi: 10.1161/JAHA.116.004168.
  11. van Sloten TT, Schram MT, van den Hurk K, Dekker JM, Nijpels G, Henry RM, Stehouwer CD. Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: the Hoorn study. J Am Coll Cardiol. 2014;63(17):1739-1747. doi: 10.1016/j.jacc.2013.12.041.
  12. Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension 2005;45(4):592-596. doi: 10.1161/01.HYP.0000159190.71253.c3.
  13. Tsuchikura S, Shoji T, Kimoto E, Shinohara K, Hatsuda S, Koyama H, Emoto M, Nishizawa Y. Brachial-­ankle pulse wave velocity as an index of central arterial stiffness. J Atheroscler Thromb. 2010;17(6):658-665. doi: 10.5551/jat.3616.
  14. Fortier C, Agharazii M. Arterial Stiffness Gradient. Pulse (Basel). 2016;3 (3-4):159-166. doi: 10.1159/000438852.
  15. Niiranen TJ, Kalesan B, Larson MG, Hamburg NM, Benjamin EJ, Mitchell GF, Vasan RS. Aortic-­Brachial Arterial Stiffness Gradient and Cardiovascular Risk in the Community: The Framingham Heart Study. Hypertension. 2017;69(6):1022-1028. doi: 10.1161/HYPERTENSIONAHA.116.08917.
  16. Fortier C, Mac-­Way F, Desmeules S, Marquis K, De Serres SA, Lebel M, Boutouyrie P, Agharazii M. Aortic-­brachial stiffness mismatch and mortality in dialysis population. Hypertension. 2015;65(2):378-384. doi: 10.1161/HYPERTENSIONAHA.114.04587.
  17. Fortier C, Sidibé A, Desjardins MP, Marquis K, De Serres SA, Mac-­Way F, Agharazii M. Aortic-­Brachial Pulse Wave Velocity Ratio: A Blood Pressure-­Independent Index of Vascular Aging. Hypertension. 2017;69(1):96-101. doi: 10.1161/HYPERTENSIONAHA.116.08409.
  18. Bao W, Wang F, Tang W. Aortic-­brachial stiffness mismatch and mortality in peritoneal dialysis patients. Kidney Blood Press Res. 2019;44(1):123-132. doi: 10.1159/000498876.
  19. Troitskaya, E.; Starostina, E.; Kotovskaya Y., Kobalava, Z. Aortic-­brachial stiffness mismatch in patients with arterial hypertension and type 2 diabetes mellitus, Artery Research 2016;16-C:60-61. doi: 10.1016/j.artres.2016.10.042.
  20. Troitskaya E.A., Starostina E.S., Kobalava Zh.D. Prevalence of subclinical damage of peripheral arteries in patients with type 2 diabetes mellitus and arterial hypertension. Clin. Pharmacol. Ther. 2017;26(4):34-38. [In Russian].
  21. Troitskaya, E.; Starostina, E.; Kobalava, Z. Aortic-­brachial stiffness mismatch in patients with arterial hypertension and type 2 diabetes mellitus, J Hypertens 2018;36, Suppl 1: e191. doi: 10.1097/01.hjh.0000539527.73341.15
  22. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-­Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-81. doi: 10.1002/art.27584.
  23. Association of rheumatologists of Russia, Federal Clinical Guidelines “Rheumatoid arthritis”. http://rheumatolog.ru/experts/klinicheskie-­rekomendacii. (Access date 15.05.2023) [In Russian].
  24. Herbert A, Cruickshank JK, Laurent S, Boutouyrie P; Reference Values for Arterial Measurements Collaboration. Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors. Eur Heart J. 2014;35(44):3122-33. doi: 10.1093/eurheartj/ehu293.
  25. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; Authors/Task Force Members:. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940.
  26. Kobalava ZD, Konradi AO, Nedogoda SV, Shlyakhto EV, Arutyunov GP, Baranova EI, Barbarash OL, Boitsov SA, Vavilova TV, Villevalde SV, Galyavich AS, Glezer MG, Grineva EN, Grinstein YuI, Drapkina OM, Zhernakova YuV, Zvartau NE, Kislyak OA, Koziolova NA, Kosmacheva ED, Kotovskaya YuV, Libis RA, Lopatin YuM, Nebiridze DV, Nedoshivin AO, Ostroumova OD, Oschepkova EV, Ratova LG, Skibitsky VV, Tkacheva ON, Chazova IE, Chesnikova AI, Chumakova GA, Shalnova SA. Shestakova M., Yakushin SS, Yanishevsky SN. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. [In Russian]. doi: 10.15829/1560-4071-2020-3-3786.
  27. Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W, Umans JG, Calhoun D, Howard BV. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol. 2009;54(18):1730-4. doi: 10.1016/j.jacc.2009.05.070.
  28. Chung JW, Lee YS, Kim JH, Seong MJ, Kim SY, Lee JB, Ryu JK, Choi JY, Kim KS, Chang SG, Lee GH, Kim SH. Reference values for the augmentation index and pulse pressure in apparently healthy Korean subjects. Korean Circ J. 2010;40(4):165-71. doi: 10.4070/kcj.2010.40.4.165.
  29. Reference Values for Arterial Stiffness’ Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J. 2010;31(19):2338-50. doi: 10.1093/eurheartj/ehq165.
  30. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-­Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106.
  31. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-­Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;140(11): e596-e646. doi: 10.1161/CIR.0000000000000678.
  32. The QRISK®2-2017 cardiovascular disease risk calculator. https://qrisk.org//. (Access date 15.05.2023).
  33. Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-­Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17-28. doi: 10.1136/annrheumdis-2016-209775
  34. Troitskaya EA, Velmakin SV, Villevalde SV, Kobalava Z. Abnormal phenotypes of 24-h blood pressure monitoring and their associations with inflammation and arterial stiffness in patients with rheumatoid arthritis. “Arterial’naya Gipertenziya” (“Arterial Hypertension”). 2019;25(4):324-336. doi: 10.18705/1607-419X-2019-25-4-324-336. [In Russian].
  35. Troitskaya E.A., Velmakin S.V., Villevalde S.V., Kobalava Z.D. Characteristics and clinical associations of arterial stiffness and subclinical atherosclerosis in patients with rheumatoid arthritis. Kardiologiia. 2018;58(7S):46-54. (In Russian). doi: 10.18087/cardio.2494
  36. Bia, D., Zócalo, Y. Physiological Age- and Sex-­Related Profiles for Local (Aortic) and Regional (Carotid-­Femoral, Carotid-­Radial) Pulse Wave Velocity and Center-to-­Periphery Stiffness Gradient, with and without Blood Pressure Adjustments: Reference Intervals and Agreement between Methods in Healthy Subjects (3-84 Years). J Cardiovasc Dev Dis. 2021;8(1):3. doi: 10.3390/jcdd8010003.
  37. Fortier C, Desjardins MP, Agharazii M. Aortic-­Brachial Pulse Wave Velocity Ratio: A Measure of Arterial Stiffness Gradient Not Affected by Mean Arterial Pressure. Pulse (Basel). 2018;5(1-4):117-124. doi: 10.1159/000480092
  38. Armstrong MK, Schultz MG, Picone DS, Sharman JE. Aortic-to-brachial artery stiffness gradient is not blood pressure independent. J Hum Hypertens. 2019;33(5):385-392. doi: 10.1038/s41371-018-0154-y.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».